1
|
Kadowaki N: The divergence and interplay
between pDC and mDC in humans. Front Biosci (Landmark Ed).
14:808–817. 2009. View
Article : Google Scholar : PubMed/NCBI
|
2
|
Zhou J, Zhou W, Bai C, Zhou Y and Wang Y:
Interdigitating dendritic cell sarcoma: case report with review of
the literature. Onkologie. 34:634–637. 2011. View Article : Google Scholar : PubMed/NCBI
|
3
|
Han HS, Lee OJ, Lim SN, An JY, Lee KM,
Choe KH, Lee KH and Kim ST: Extranodal interdigitating dendritic
cell sarcoma presenting in the pleura: a case report. J Korean Med
Sci. 26:304–307. 2011. View Article : Google Scholar : PubMed/NCBI
|
4
|
Ye Z, Liu F, Cao Q and Lin H:
Interdigitating dendritic cell sarcoma of lymph node mimicking
granuloma: a case report and review of the literature. Pol J
Pathol. 62:274–277. 2011.PubMed/NCBI
|
5
|
Parada D, Peña KB, Gil I, Queralt R,
Garcia A and Alos L: Interdigitating dendritic cell sarcoma
presenting in the nasal region. Pathol Res Pract. 208:368–371.
2012. View Article : Google Scholar : PubMed/NCBI
|
6
|
Shvarts O, Han KR, Lam JS and Belldegrun
AS: Primary leiomyosarcoma of the inferior vena cava presenting as
a renal mass. Rev Urol. 6:39–42. 2004.PubMed/NCBI
|
7
|
De Pas T, Spitaleri G, Pruneri G,
Curigliano G, Noberasco C, Luini A, Andreoni B, Testori A and de
Braud F: Dendritic cell sarcoma: an analytic overview of the
literature and presentation of original five cases. Crit Rev Oncol
Hematol. 65:1–7. 2008.PubMed/NCBI
|
8
|
Perkins SM and Shinohara ET:
Interdigitating and follicular dendritic cell sarcomas: a SEER
analysis. Am J Clin Oncol. 36:395–398. 2013. View Article : Google Scholar : PubMed/NCBI
|
9
|
Nayer H, Murphy KM, Hawkins AL, Long PP,
Gillison M, Borowitz M and Griffin CA: Clonal cytogenetic
abnormalities and BCL2 rearrangement in interdigitating dendritic
cell sarcoma. Leuk Lymphoma. 47:2651–2654. 2006. View Article : Google Scholar : PubMed/NCBI
|
10
|
Wang HY, Li S, Woodford RL, Mills SE and
Cousar JB: BCL2 chromosomal translocation is not a general feature
of the interdigitating dendritic cell sarcoma. Diagn Mol Pathol.
19:169–171. 2010. View Article : Google Scholar : PubMed/NCBI
|
11
|
Olnes MJ, Nicol T, Duncan M, Bohlman M and
Erlich R: Interdigitating dendritic cell sarcoma: a rare malignancy
responsive to ABVD chemotherapy. Leuk Lymphoma. 43:817–821. 2002.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Lee SY, Lee SR, Chang WJ, Kim HS, Kim BS
and Kim IS: Successful treatment of disseminated interdigitating
dendritic cell sarcoma with adriamycin, bleomycin, vinblastine, and
dacarbazine chemotherapy. Korean J Hematol. 47:150–153. 2012.
View Article : Google Scholar
|
13
|
Paal E and Miettinen M: Retroperitoneal
leiomyomas: a clinicopathologic and immunohistochemical study of 56
cases with a comparison to retroperitoneal leiomyosarcomas. Am J
Surg Pathol. 25:1355–1363. 2001. View Article : Google Scholar : PubMed/NCBI
|
14
|
Kyriazi MA, Stafyla VK, Chatzinikolaou I,
Koureas A, Chatziioannou A, Kondi-Paphiti A, Arkadopoulos N and
Smyrniotis V: Surgical challenges in the treatment of
leiomyosarcoma of the inferior vena cava: analysis of two cases and
brief review of the literature. Ann Vasc Surg. 24:826.e13–17. 2010.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Theodosopoulos T, Psychogiou V, Yiallourou
AI, Polymeneas G, Kondi-Pafiti A, Papaconstantinou I and Voros D:
Management of retroperitoneal sarcomas: main prognostic factors for
local recurrence and survival. J BUON. 17:138–142. 2012.PubMed/NCBI
|
16
|
Yamashita R, Muraoka K, Matsuzaki M,
Matsui T, Yamaguchi R, Niwakawa M, Tobisu K and Ito I:
Clinicopathological study of retroperitoneal sarcoma. Nihon
Hinyokika Gakkai Zasshi. 102:628–632. 2011.(In Japanese).
|